Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell

NCT00447460 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Graft-vs-Host Disease (GVHD)

Interventions

PROCEDURE: Mesenchymal stem cell (MSC)

Sponsor

University of Salamanca

Collaborators

[object Object]